MARKET

CTMX

CTMX

Cytomx Therapeutics Inc
NASDAQ
1.490
+0.040
+2.76%
Pre Market: 1.440 -0.05 -3.36% 05:29 10/04 EDT
OPEN
1.470
PREV CLOSE
1.450
HIGH
1.510
LOW
1.450
VOLUME
200
TURNOVER
--
52 WEEK HIGH
7.53
52 WEEK LOW
1.190
MARKET CAP
98.27M
P/E (TTM)
-1.0053
1D
5D
1M
3M
1Y
5Y
CytomX Therapeutics, Inc. (NASDAQ:CTMX) institutional owners may be pleased with recent gains after 68% loss over the past year
A look at the shareholders of CytomX Therapeutics, Inc. ( NASDAQ:CTMX ) can tell us which group is most powerful. And...
Simply Wall St. · 09/13 12:42
BRIEF-CytomX Announces Phase 1 Data Update For Anti-CTLA-4 Probody Therapeutic BMS-986249
BRIEF-CytomX Announces Phase 1 Data Update For Anti-CTLA-4 Probody Therapeutic BMS-986249
Reuters · 09/12 13:39
CytomX Therapeutics Highlights Collaborator Bristol Myers Squibb's ESMO 2022 Preentatoin
SOUTH SAN FRANCISCO, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of conditionally activated oncology therapeutics, today announced that its collaborator,
Benzinga · 09/12 12:17
CytomX Therapeutics Presented Overview of Conditionally-Activated Antibody-Drug Conjugate Programs Including Next Generation EpCAM-Targeting CX-2051 at World ADC Conference
CytomX Therapeutics, Inc. (Nasdaq: CTMX) today announced that the Company presented advances within its conditionally-activated ADC portfolio, including the next generation EpCAM-ADC, CX-2051, at the World ADC conference taking place September 6-9, 2022, in San Diego, CA.
Benzinga · 09/07 22:57
CytomX Therapeutics Presents Overview of Conditionally-Activated Antibody-Drug Conjugate (ADC) Programs Including Next Generation EpCAM-Targeting CX-2051
- Presentation at World ADC Conference in San Diego - - CX-2051 integrates CytomX core platform expertise to potentially maximize therapeutic window - SOUTH SAN FRANCISCO, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX),...
GlobeNewswire · 09/07 22:05
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.
Benzinga · 09/07 09:16
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session
Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners.
Benzinga · 09/06 17:36
IVERIC, First Wave top healthcare gainers; Eiger, bioAffinity lead losers' pack
Gainers: IVERIC bio (ISEE) +37%. First Wave BioPharma (<a href="https:/...
Seekingalpha · 09/06 14:07
More
About CTMX
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company is developing a class of investigational conditionally activated therapeutics, based on its Probody technology platform, for the treatment of cancer. Its Probody technology platform is designed to enable conditional activation of antibody-based drugs in the tumor microenvironment while minimizing drug activity in healthy tissues and in circulation. The Company's product candidates include the conditionally activated antibody-drug conjugates (ADCs) praluzatamab ravtansine (CX2009, targeting CD166) and CX-2029, targeting CD71, and the Probody immune checkpoint inhibitors pacmilimab (CX-072, targeting PD-L1) and BMS-986249 (targeting CTLA-4). It also has two preclinical agents in investigational new drug (IND)-enabling studies - a conditionally activated ADC targeting EpCAM/Trop-1 (CX-2043) and a conditionally activated T-cell engaging bispecific antibody targeting EGFR and CD3 (CX-904).

Webull offers kinds of CytomX Therapeutics Inc stock information, including NASDAQ:CTMX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTMX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CTMX stock methods without spending real money on the virtual paper trading platform.